Bio Green Med Solution, Inc. (BGMS)
Official siteINDUSTRIALS • BUILDING PRODUCTS & EQUIPMENT • NASDAQ
Market Cap: $4.31M
Last updated: Nov 17, 2026 at 4:32 PM ET
Bio Green Med Solution, Inc. (BGMS) Statistics
Bio Green Med Solution (BGMS) has a market cap of $4.31M and an enterprise value of $852.10K. Revenue grew 2658.02% over the last 12 months from the 12 months before. Its share count is up 246.29% from a year earlier.
Total Valuation
Enterprise value is 80.21% below the market cap, as cash exceeds debt.
| Market Cap | $4.31M |
|---|---|
| Enterprise Value | $852.10K |
| Latest price (Nov 17, 2026) | $0.58 |
Key Dates
The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 29, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 12, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.7x and 0.6x. Its year-end P/S ranged from 7.9x to 21.4x from 2016 to 2025.
| P/S Ratio | 1.7x |
|---|---|
| P/B Ratio | 0.6x |
| P/TBV Ratio | 0.8x |
Price Statistics
The stock is down 55.50% over 52 weeks and trades 34.09% below its 50-day average.
| Beta (1Y) | 0.72 |
|---|---|
| 52-Week Change | -55.50% |
| 1-Month Change | -37.51% |
| 3-Month Change | -35.60% |
| 6-Month Change | -39.33% |
| 5-Year Change | -99.99% |
| 10-Year Change | -100.00% |
| Total Return (1Y) | -55.50% |
| Total Return (3Y CAGR) | -90.71% |
| Total Return (5Y CAGR) | -85.88% |
| Max Drawdown (1Y) | -67.97% |
| Max Drawdown (3Y) | -99.92% |
| Sharpe Ratio (1Y) | -0.76 |
| Correlation with SPY (1Y) | 0.09 |
| 50-Day Average | $0.88 |
| 200-Day Average | $0.93 |
| 52-Week Range | $0.57 to $1.84 |
| RSI (14 Days) | 28.5 |
| Average Volume (20 Days) | 21.10K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 6.84x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 6.84x |
|---|---|
| Quick Ratio | 5.63x |
| Debt / Equity | 0.00x |
| Interest Coverage | 16.09x |
Returns and Efficiency
Return on equity is -24.95% and return on assets is -22.23% over the last 12 months.
| Return on Equity (ROE) | -24.95% |
|---|---|
| Return on Assets (ROA) | -22.23% |
| Asset Turnover | 0.29x |
| Inventory Turnover | 1.81x |
| Receivables Turnover | 2.18x |
| Cash Conversion Cycle | 331 days |
Scores
BGMS has an Altman Z-Score of -82.13, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -82.13 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $2.23M over the last 12 months.
| Revenue | $2.23M |
|---|---|
| Revenue Growth (YoY) | +2658.02% |
| Gross Profit | $458.00K |
| Operating Income | -$2.27M |
| Pretax Income | -$1.61M |
| Net Income | -$1.66M |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 89.04% of the $7.48M in total assets.
| Cash and Equivalents | $3.45M |
|---|---|
| Total Debt | $0 |
| Net Cash | $3.45M |
| Net Cash Per Share | $0.52 |
| Working Capital | $4.76M |
| Shareholder Equity | $6.66M |
| Book Value Per Share | $1.01 |
| Tangible Book Value | $5.09M |
| Tangible Book Per Share | $0.77 |
| Total Assets | $7.48M |
| Total Liabilities | $817.00K |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$950.00K |
|---|---|
| FCF Per Share | -$0.14 |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -101.43%.
| Gross Margin | 20.50% |
|---|---|
| Operating Margin | -101.43% |
| Pretax Margin | -72.29% |
| Net Margin | -74.40% |
Stock Splits
The last split was a 1-for-15 reverse split on Jul 7, 2025.
| Last Split Date | Jul 7, 2025 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:15 |
Peer Position
Against 6 similar companies, BGMS has the 2nd highest P/S.
P/S RatioPeer median 0.8x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +31.82%
| P/S Ratio | 1.7x vs 0.8x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | +2658.02% vs +31.82% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About BGMS
What is BGMS's market cap?
Bio Green Med Solution has a market cap of $4.31M. Its enterprise value, which adds debt and subtracts cash, is $852.10K.
How many shares of BGMS are outstanding?
Bio Green Med Solution has 6.62M shares outstanding. The count is up 246.29% from a year earlier.
Does BGMS pay a dividend?
No. Bio Green Med Solution does not pay a dividend.
How much debt does BGMS have?
Bio Green Med Solution has $0 of total debt and $3.45M of cash and equivalents, a net cash position of $3.45M.
BGMS pages: Overview, Charting, Earnings, Financials, Statistics, Valuation, Competitors